Background: Anthocyanins (ACNs) are the most prevalent flavonoids in berries and their health
INTRODUCTION
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in the Western population and it was postulated that the consumption of fruit and vegetables has been postulated to be associated with reduced risk for CVD. 1, 2 Despite the controversial results from epidemiological observations or intervention studies, current research has been focusing on the so-called low-grade inflammation (LGI), which is considered to be the first step in the pathogenesis of several inflammation associated diseases such as atherosclerosis, obesity, diabetes and cancer. 3, 4 There are many causes for a LGI with lifestyle factors playing a major role. 5, 6, 7 At first, dietary factors such as a high fat diet, low dietary fiber or polyunsaturated fat are associated with LGI. 8 LGI is characterized by enhanced circulating cytokines (TNF-α, IL-6), chemokines (IL-8) or acute phase proteins such as CRP (C-reactive peptide) leading to an activation of vascular endothelium and impairment. The activation of endothelial cells during inflammatory processes is a well-known multistep process in which multiple cell adhesion molecules are expressed in a time-and concentration-dependent manner. 9 Thus, after endothelial activation, cell adhesion molecules such as E-selectin, mediating the first cell-cell interactions between leukocytes and the vascular endothelium and molecules of the immunoglobulin superfamily (intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)), responsible for the firm adhesion and transmigration of the cells to the extravasal space, have been reported to play a major role in the initial steps of atherosclerotic pathogenesis. 10, 11, 12 As a consequence, prolonged and chronic activation of the vascular epithelium may lead to thrombotic vessel closure and plaque rupture. 13, 14 Recently, it has been shown that consumption of blueberries improved endothelial dysfunction and reduced inflammatory markers in subjects with increased cardiovascular risk. 15 Furthermore, ingestion of bilberries by individuals with features of metabolic syndrome was associated with a reduction of
LGI. 16 Such effects of fruits, especially berries have been mainly attributed to the presence of polyphenols and their anti-oxidative, anti-inflammatory and anti-adhesive effects, and may exert positive effects on vascular function. 3, 17 Flavonoids are the most prevalent group of polyphenols in fruits, with flavonols, flavanones and ACNs as the most important subgroups. 18 For example, the flavanones naringenin and hesperitin as well as their chemically synthesized glucuronides and sulfates were able to reduce monocyte adhesion to HUVEC monolayers under low-grade inflammation. 19 This could also be observed using flavonol glucuronides like quercetin 3'-sulfate, quercetin 3-glucuronide or 3'-methylquercetin 3-glucuronide. 20 In contrast to flavonoids, effects of ACNs were only measured using single compounds and/or used in supraphysiological concentrations. However, ACNs can be directly absorbed in the intestine without prior chemical modification or after deglycosylation and could be further metabolized by phase II enzyme into methyl, glucuronide, or sulfate conjugates in the small intestine and in the liver. 21 Keeping in mind that the concentration of glycosides of ACNs were extremely low or absent in plasma and that intense metabolization in the intestinal epithelial cells generated phase II metabolites (glucuronidation, sulphation and methylation), it seems conceivable that metabolites are the relevant bioactive components. Furthermore, there is increasing evidence that degradation products rather than the parental compounds were responsible for the health effects. This involves the formation of phenolic and aromatic acids such as hydroxybenzoic or hydroxycinnamic acids, which could also have an endothelium protecting effect. 22, 23 The aim of the present study was to investigate degradation, transport and metabolization of ACNs from an ACN-rich grape extract as well as malvidin-3-glucoside (M3G) and protocatechuic acid (PCA) 
METHODS AND MATERIALS

Materials
M3G was purchased from Carl Roth GmbH (Karlsruhe, Germany), PCA from Sigma-Aldrich (Taufkirchen, Germany), TNF-α from R&D (Heidelberg, Germany), Calcein-AM and human plasma fibronectin from Invitrogen (Heidelberg, Germany). Cell culture media and supplements for human umbilical vein endothelial cells (HUVECs) were obtained from Promocell (Heidelberg, Germany), and those for Caco-2 cells and HT29-B6 cells from Invitrogen (Heidelberg, Germany). All chemicals were with analytical grade and cell culture tested.
Methods
Anthocyanin-rich grape extract. The ACN-rich grape extract was produced at the University UPLC separation was performed using an UltiMate 3000 RSLC (Rapid Separation LC) (Dionex, Idstein, Germany) system equipped with a pump (HPG 3200 RS), an autosampler (WPS-3000 TRS) and a 100 mm x 2.1 mm ID, 2.6 µm particle size, Kinetex reversed phase Epithelial and endothelial cells and culture conditions. were subjected to an octadecylsilane solid-phase extraction (SPE) cartridge (HLB; Waters Corp., Milford, MA) following the method described previously. 32 In a second set of experiments, intestinal cell inserts were removed after 240 min of incubation and basolateral compartments containing HUVECs grown on fibronectin were immediately stimulated for 3 hours using 1 ng/mL or 10 ng/mL TNF-α to mimic low-grade or high grade inflammation (short-term incubation). To determine long-term effects of ACNs, HUVECs were cultured for further 20 hours and thereafter stimulated with both TNF-α concentrations (see Figure 1 ).
Intestinal cells (Caco-2 and HT29-B6 cells
Cell adhesion assay. In order to evaluate leukocyte adhesion to HUVECs, we isolated leukocytes from blood as described previously. 33 To stain viable cells, 0. 10 mM dithiothreitol, 100 ng oligodeoxythymidine 15 primer, 500 µmoL/L of each deoxynucleotide triphosphate (dATP, dGTP, dCTP and dTTP), 10 U ribonuclease inhibitor, and 200 U MulV (Moloney murine leukemia virus reverse transcriptase); all reagents were obtained from Invitrogen (Invitrogen, Karlsruhe; Germany). The samples were incubated at 37°C for 60 min, followed by an incubation at 95°C for 15 min. mRNA expression of target genes was measured in HUVECs using the 7500 Real-Time PCR System (Applied Biosystems, Darmstadt, Germany). Gene-specific primers and probes used in this study ( Table 2) were designed using the sequences accessible in the NCBI Reference Sequence and the Primer Express In all cases, degradation rates in the presence of cells were significantly higher than the Differences were significant at *p < 0.05 compared to the initial concentrations.
RESULTS
ACNs degradation and incubation studies with culturing
Establishment of low-grade and high-grade inflammatory conditions in HUVECs stimulated
with TNF-α α α α. In order to distinguish between low-grade inflammation to mimic an in vivo LGI and a chronic (high-grade) inflammation, HUVECs were stimulated with different concentrations of TNF-α for 3 hours. Thereafter, inflammation-related parameters were measured as described in "materials and methods". The determination of leukocyte adhesion to HUVECs with the adhesion assay showed that adhesion was significantly increased by low-grade (1 ng/mL, To compare the anti-inflammatory effects of ACNs with controls, values of the positive controls (TNF-α stimulated cells, low-grade and high-grade) were set to 100% and inhibition by ACNs, M3G or PCA was compared to the positive control (n=3). Thereafter, cells were stimulated for 3 hours using 1 ng/mL TNF-α (low-grade inflammation) or 10 ng/mL TNF-α (high-grade inflammation). After TNF-α stimulation, leukocyte adhesion was measured as described in the Material and Methods section. Corresponding controls (maximal adhesion to HUVECs after low-grade or high-grade TNF-α stimulation) were set to 100%.
Inhibition of leukocyte adhesion to HUVECs by
Values are given as mean ± SD (n=3). Differences were significant at *p < 0.05 and **p < 0.01. 
Inhibition of adhesion molecules expression on HUVECs under low-grade inflammatory
conditions. Since our results from the adhesion assays were significant for inhibiting low-grade inflammation and were only observed using 100% Caco-2 cells, these conditions were chosen for subsequent experiments. For the quantification of cell adhesion molecules on mRNA and protein levels, we either used the media from the basolateral compartments from the co-culture system or directly incubated HUVECs with ACNs from extract, M3G and PCA. Direct incubation was performed with ACNs (0.1 or 1 µmoL/L M3G equivalents) or M3G and PCA (0.1 or 1 µmoL/L). Figure 5 A and B) . ACNs significantly inhibited the TNF-α induced adhesion molecule mRNA and protein expression with a greater effect on ICAM-1 and VCAM-1 than on E-selectin. ACNs of basolateral concentrations could significantly inhibit protein levels of adhesion molecules to 66 ± 5, 52 ± 7 and 59 ± 9 % of TNF-α stimulated controls and 76 ± 29, 40 ± 10 56 ± 14 % of the TNF-α stimulated mRNA levels of E-selectin, ICAM-1 and VCAM-1, respectively. Similar to ACNs, M3G significantly reduced the expression of the three adhesion molecules to 86 ± 6, 72 ± 6 and 71 ± 12 % of the protein level for E-selectin, ICAM-1 and VCAM-1 as well as to 50 ± 10, 66 ± 12 and 60 ± 10 % of the TNF-α-induced mRNA levels for E-selectin, ICAM-1 and VCAM-1. PCA could also significantly alter TNF-α-induced protein and mRNA expression levels, with 83 ± 9, 61 ± 7 and 61 ± 4% of the protein levels and 79 ± 10, 80 ± 10 and 64 ± 13% of the mRNA levels for E-selectin, ICAM-1 and VCAM-1. No effect was observed on IL-6 mRNA and protein expression.
The adhesion and anti-inflammatory effects of ACNs, M3G and PCA correlated with the effects on NF-κB mRNA levels. The amount of NF-κB mRNA was significantly reduced by ACNs from the basolateral compartment of the transwell systems. They reduced TNF-α stimulated mRNA levels to 69 ± 10%. Similar to ACNs, M3G and PCA significantly decreased the expression of NF-kB mRNA levels to 84 ± 10% and 81± 9% of TNF-α stimulated mRNA levels. This effect was greater, when HUVECs were directly incubated. ACNs, M3G and PCA reduced the mRNA levels to 56 ± 15% and 72 ± 16% and 73±6% of the TNF-α induced expression when using 1 µmoL/L equivalents, but no effect was observed when 0.1 µmoL/L was used for pre-incubation. Corresponding controls were set to 100%. Values are given as mean ± SD (n=3). Differences were significant at *p < 0.05, **p < 0.01 and ***p < 0.001. 34, 35, 36 These physiological concentrations were able to induce systemic effects. 37, 38 However, it is well-known, that ACNs are relatively instable and undergo chemical degradations at physiological pH (pH 7.2), a pH value existing in the intestine and colon. 39, 40 Furthermore, ACNs which reach the intestine, could be absorbed without modification or after enzymatic hydrolyzation of the attached sugar. 41 Once absorbed, they could be further metabolized by phase-II-enzymes.
suggested to be dependent on the distribution pattern with enzyme-dependent differences along the intestine. 43 Thus, we investigated ACN transport using Caco concentration could be found in the basolateral solution. These differences in the apical disappearance respectively basolateral occurrence of intact glucosides could be a consequence of ß-glucosidase activities or lower transport capacities. Enzymes such as the brush border associated LPH (lactase phlorizin hydrolase) act on ß-glucosidic cleavage to release the aglycone as shown for flavonols like quercetin. 44 Both, the aglycone of quercetin as well as quercetin-3-glucoside were able to inhibit GLUT2 mediated glucose transport. 45 Similar results were obtained with the ACNs pelargonidin-3-glucoside or M3G, which inhibit glucose transport primarily by inhibition of GLUT2 with less inhibition of SGLT1. 41, 46 This, however, must remain speculative, since we have not measured enzyme activities or inhibition of glucose transport.
Nevertheless, in all three intestinal models we did not only measure the occurrence of ACNs from grape extract in basal compartments, but also that of M3G when applied as a single compound. In both cases, the transport efficiencies were low and recovery rates were less than secretion. 55 Although they used a high concentration of TNF-α of 10 µg/mL, they observed effects of M3G already at low concentrations (1µmoL/L). The reason might have been that they reduced serum concentrations in HUVEC culture media prior to their pre-incubation experiments with M3G. Chao et al on the other hand showed that 100 µg/mL purple sweet potato leaf extract (PSPLE) and its major ACN cyanidin attenuated TNF-α (2 ng/mL) induced VCAM-1 expression in human aortic endothelial cells (HAECs). 56 Hidalgo et al reported that the TNF-α induced ICAM-1 and VCAM-1 expression levels were dose-dependently reduced when using high concentrations of possible breakdown products of ACNs such as gallic acid (10-100 µM). 57 This also applies to PCA for which Zhou et al have shown that high concentrations (150 µM) inhibited TNF-α induced (10 ng/mL) up-regulation of lymphoma cell (U937) adhesion to HUVECs. 58 Furthermore, PCA inhibited TNF-α stimulated VCAM-1 and ICAM-1 expression through mechanisms involving the transcription factors NF-kB and AP1. Keeping in mind that PCA or gallic acid concentrations in plasma were found to be low under physiological conditions, concentrations used in vitro were much higher. 59 In our study, the expression of NF-κB mRNA in these changes were significant, whereas no effect was observed with short-term exposure and high-grade inflammation. A limitation of the study was that the observed effects may not only be a result of parenteral anthocyanins, but rather an effect of unidentified metabolites. In further studies, a focus should be put on the identification and characterization of anthocyanins and their metabolites which would give information on which ACN metabolites were responsible for the effects. Although it is difficult to directly transfer these data to the in vivo situation, our results support the hypothesis that ACNs or their degradation protect against inflammation-induced atherogenesis.
